NBSE — NeuBase Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet
U.S. STOCKS ON THE MOVE-Berkshire Hathaway, Intuitive Machines, Amer Sports
NeuBase rises on plan to liquidate and distribute its assets
Brief: Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets
NeuBase climbs after CEO change
Brief: Neubase Therapeutics Board Terminated Employment Of Dietrich Stephan As CEO
Brief: Neubase Therapeutics Says Carnegie Mellon University Terminated License Agreement
Brief: Neubase Therapeutics On November 3 Received Letter From Nasdaq, Notifying Co Has Not Satisfied Minimum Bid Price Requirement
Brief: Symetryx Corporation Says On Sept 13, Sent An Email To Neubase Therapeutics Proposing Specific Company As Potential Merger Candidate
Brief: Neubase Therapeutics Issues Statement Regarding Filing By Shareholder
U.S. STOCKS ON THE MOVE-Comcast, Apple, Lockheed Martin
NeuBase Therapeutics soars as Symetryx acquires 20% of co's shares
Brief: Symetryx Corp Reports 13.8% Stake In Neubase Therapeutics As Of August 22
NeuBase Therapeutics Inc expected to post a loss of $2.00 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-EPAM Systems, Intevac, Amgen
U.S. STOCKS ON THE MOVE-Traeger, Apollo, HF Sinclair